NUFEXULT
Live / Registered — Registered (as of 29 Sept 2026)
What this means for you
Registered since 29 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Sept 2032: the §71 affidavit of use).
Record
- Serial number
- 79439792
- Registration number
- 8465763
- Mark type
- Word mark
- Filed
- 21 Nov 2025
- Published for opposition
- 11 Aug 2026
- Registered
- 29 Sept 2026
- Next maintenance filing
- §71 affidavit of use, due by 29 Sept 2032 (grace period to 29 Mar 2033)
- Attorney of record
- Maren C. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the diagnosis, prevention and treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP); pharmaceutical preparations and substances for the prevention and treatment of restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents and preparations for medical purposes
Owner
- H. Lundbeck A/S, DK
- H. Lundbeck A/S, DK
- H. Lundbeck A/S, DK
Prosecution history
- 29 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Aug 2026 — PUBLISHED FOR OPPOSITION
- 05 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Mar 2026 — REFUSAL PROCESSED BY IB
- 26 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 26 Feb 2026 — REFUSAL PROCESSED BY MPU
- 30 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 29 Jan 2026 — NON-FINAL ACTION WRITTEN
- 29 Jan 2026 — ASSIGNED TO EXAMINER